Journal of Neurology

, 255:1324 | Cite as

Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia

  • N. Ibarretxe-Bilbao
  • B. Ramírez-Ruiz
  • E. Tolosa
  • M. J. Martí
  • F. Valldeoriola
  • N. Bargalló
  • C. Junqué
ORIGINAL COMMUNICATION

Abstract

We studied regional gray matter density in the hippocampus in Parkinson’s disease (PD) patients. We obtained magnetic resonance scans in 44 PD patients (PD patients with dementia (PDD) = 9, non-demented PD patients with visual hallucinations (PD + VH) = 16, and PD patients without dementia and without visual hallucinations (PD - VH) = 19) and 56 controls matched for age and years of education. A region of interest (ROI) of the hippocampus following voxel-based morphometry (VBM) procedures was used to perform group comparisons, single-case individual analysis and correlations with learning scores. Group comparisons showed that PDD patients and PD+VH patients had significant hippocampal gray matter loss compared to controls. In PDD patients, hippocampal gray matter loss involved the entire hippocampus and in PD+VH this reduction was mainly confined to the hippocampal head. 78 % of PDD patients, 31 % of PD+VH patients and 26 % of PD-VH patients had hippocampal head gray matter loss when compared to controls. These results suggest that in PD the neurodegenerative process in the hippocampus starts in the head of this structure and later spreads to the tail and that, in addition, memory impairment assessed by Rey’s Auditory Verbal Learning Test (RAVLT) correlates with hippocampal head gray matter loss.

Key words

Parkinson’s disease dementia hallucinations MRI hippocampus 

References

  1. 1.
    Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387–392PubMedCrossRefGoogle Scholar
  2. 2.
    American Psychiatric Association (2003) Manual diagnóstico y estadístico de los trastornos mentales, Cuarta edición revisada: DSM-IV-TR. Masson SA, BarcelonaGoogle Scholar
  3. 3.
    Apostolova L, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM (2006) Conversión of mild cognitive imapirment to Alzheimer’s disease predicted by hippocampal atrophy maps. Arch Neurol 63:693–699PubMedCrossRefGoogle Scholar
  4. 4.
    Ashburner J, Friston KJ (2000) Voxelbased morphometry – the methods. Neuroimage 11:805–821PubMedCrossRefGoogle Scholar
  5. 5.
    Beyer MK, Janvin CC, Larsen JP, Aarsland D (2007) An MRI study of patients with Parkinson’s disease with mild cognitive impairment using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78:254–259PubMedCrossRefGoogle Scholar
  6. 6.
    Bouchard TP, Malykhin N, Martin WRW, Hanstock CC, Emery DJ , Fisher NJ , Camicioli RM (2007) Age and dementia-associated atrophy predominates in the hippocampal head and amygdale in Parkinson’s disease. Neurobiol Aging 29:1027–1039PubMedCrossRefGoogle Scholar
  7. 7.
    Braak H, Del Tredici K, Rüb U, de Vos RAI, Ernst NH, Steur J, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRefGoogle Scholar
  8. 8.
    Burn DJ (2004) Cortical Lewy body disease. J Neurol Neurosurg Psychiatry 75:175–178PubMedCrossRefGoogle Scholar
  9. 9.
    Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson’s disease is associated with hippocampal athophy. Mov Disord 18:784–790PubMedCrossRefGoogle Scholar
  10. 10.
    Churchyard A, Lees AJ (1997) The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson’s disease. Neurology 49:1570–1576PubMedGoogle Scholar
  11. 11.
    Daniel SE, Lees AJ (1993) Parkinson’s Disease Society Brain Bank, London: overview and research. J Neural Transm 39(Suppl):165–172Google Scholar
  12. 12.
    Duvernoy HM (1998) The human hippocampus: An atlas of applied anatomy. Berlin: Springer-VerlagGoogle Scholar
  13. 13.
    Fahn S, Elton RL, and members of the UPDRS development committee (1987) Unified Idiopathic Parkinson’s disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recents developments in Parkinson’s disease (Vol. 2). Florham Park, New Jersey, Mac Millan Healthcare Information; USA, pp 153–164Google Scholar
  14. 14.
    Folstein MF, Folstein SE, MCHugh PR (1975) “Mini.mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRefGoogle Scholar
  15. 15.
    Frisoni GB, Sabattoli F, Lee AD, Dutton RA, Toga AW, Thompson PM (2006) In vivo neuropathology of the hippocampal formation in AD. A radial mapping MR-based study. Neuroimage 32:104–110PubMedCrossRefGoogle Scholar
  16. 16.
    Frisoni GB, Testa C, Zorzan A, Sabattoli F, Beltramello A, Soininen H, Laakso MP (2002) Detection of grey matter loss in mild Alzheimer’s disease with voxel based-morphometry. J Neurol Neurosurg Psychiatry 73:657–664PubMedCrossRefGoogle Scholar
  17. 17.
    Galvin JE, Pollack J, Morris JC (2006) Clinical phenotype of Parkinson disease in dementia. Neurology 67:1605–1611PubMedCrossRefGoogle Scholar
  18. 18.
    Hackert VH, den Heijer T, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MB (2002) Hippocampal head size associated with memory performance in nondemented elderly. Neuroimage 17:1365–1372PubMedCrossRefGoogle Scholar
  19. 19.
    Hamilton M (1996) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62CrossRefGoogle Scholar
  20. 20.
    Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RHS, Spokes EGS (2000) A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology 54:1596–1603PubMedGoogle Scholar
  21. 21.
    Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, Stern M, Tanner C, Weiner W and the Parkinson Study Group (1990) Variable expression of Parkinson’s disease: A base-line analysis of the DATATOP cohort. Neurology 40:1529–1534PubMedGoogle Scholar
  22. 22.
    Junque C, Ramirez-Ruiz B, Tolosa E, Summerfield C, Martí MJ, Pastor P, Gómez-Ansón B, Mercader (2005) Amygdalar and hippocampal MRI volumetric reductions in Parkinson’s disease with dementia. Mov Disord 20:540–544PubMedCrossRefGoogle Scholar
  23. 23.
    Laakso MP, Frisoni GB, Könönen M, Mikkonen M, Beltramello A, Geroldi C, Bianchetti A, Trabucchi M, Soininen H, Aronen HJ (2000) Hippocampus and entorhinal cortex in frontotemproal dementia and Alzheimer’s disease: a morphometric MRI study. Biol Psychiatry 47:1056–1063PubMedCrossRefGoogle Scholar
  24. 24.
    Laakso MP, Partanen K, Riekkinen PJ, Lehtovirta M, Helkala EL, Hallikainen M, Hanninen T, Vainio P, Soininen H (1996) Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia: An MRI study. Neurology 46:678–681PubMedGoogle Scholar
  25. 25.
    Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS (2004) Neuropsychological assessment. 4th ed. Oxford University Press Inc, New YorkGoogle Scholar
  26. 26.
    Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19:1233–1239PubMedCrossRefGoogle Scholar
  27. 27.
    Mechelli A, Price CJ, Friston KJ, Ashburner J (2005) Voxel-based morphometry of the human brain: Methods and applications. Current Medical Imaging Reviews 1:105–113CrossRefGoogle Scholar
  28. 28.
    Pruessner JC, Collins DL, Pruessner M, Evans AC (2001) Age and gender predict volume decline in the anterior and posterior hippocampus in early adulthood. J Neurosci 21:194–200PubMedGoogle Scholar
  29. 29.
    Ramírez-Ruiz B, Junque C, Martí MJ, Valldeoriola F, Tolosa E (2007) Cognitive changes in Parkinson’s disease patients with visual hallucinations. Dement Geriatr Cogn Disord 23:281–288PubMedCrossRefGoogle Scholar
  30. 30.
    Ramírez-Ruiz B, Junqué C, Martí MJ, Valldeoriola F, Tolosa E (2006) Neuropsychological deficits in Parkinson’s disease patients with visual hallucinations. Mov Disord 21:1483–1487PubMedCrossRefGoogle Scholar
  31. 31.
    Ramírez-Ruiz B, Marti MJ, Tolosa E, Bartrés-Faz D, Summerfield D, Salgado-Pineda P, Gómez-Ansón B, Junqué C (2005) Longitudinal evaluation of cerebral morphological changes in Parkinson’s disease with and without dementia. J Neurol 252:1345–135PubMedCrossRefGoogle Scholar
  32. 32.
    Ramírez-Ruiz B,Martí MJ, Tolosa E, Giménez M, Bargalló N, Valldeoriola F, Junqué C (2007) Cerebral atrophy in Parkinson’s disease patients with visual hallucinations. Eur J Neurol 14:750–756PubMedCrossRefGoogle Scholar
  33. 33.
    Saldmond CH, de Haan M, Friston KJ, Gadian DG, Vargha-Khadem F (2003) Investigating individual differences in brain abnormalities in autism. Phil Trans R Soc London B 358:405–413CrossRefGoogle Scholar
  34. 34.
    Summerfield C, Junqué C, Tolosa E, Salgado-Pineda P, Gómez-Ansón B, Martí MJ, Pastor P, Ramírez-Ruíz B, Mercader J (2005) Structural Brain Changes in Parkinson Disease with Dementia. Arch Neurol 62:281–285PubMedCrossRefGoogle Scholar
  35. 35.
    Tam CW, Burton EJ, McKeith IG, Burn DJ, O’Brien JT (2005) Temporal lobe atrophy on MRI in Parkinson’s disease with dementia: A comparison with Alzheimer’s disease and dementia with Lewy bodies. Neurology 64:861–865PubMedGoogle Scholar
  36. 36.
    Wang L, Swank JS, Glick IE, Mokhtar HG, Miller MI, Morris JC, Csernansky JG (2003) Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage 20:667–682PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • N. Ibarretxe-Bilbao
    • 1
    • 2
  • B. Ramírez-Ruiz
    • 1
    • 2
  • E. Tolosa
    • 2
    • 3
  • M. J. Martí
    • 2
    • 3
  • F. Valldeoriola
    • 2
    • 3
  • N. Bargalló
    • 2
    • 4
  • C. Junqué
    • 1
    • 2
  1. 1.Dept. of Psychiatry and Clinical, PsychobiologyUniversity of Barcelona, IDIBAPSBarcelonaSpain
  2. 2.Institute of Biomedical ResearchAugust Pi i Sunyer (IDIBAPS)BarcelonaSpain
  3. 3.Parkinson’s disease and Movement, Disorders Unit, Neurology ServiceInstitut Clínic de Malalties del Sistema, Nerviós, Hospital Clínic de BarcelonaBarcelonaSpain
  4. 4.Centre de Diagnòstic per la ImatgeHospital Clinic de Barcelona (CDIC)BarcelonaSpain

Personalised recommendations